HR. 1262Introduced
Mikaela Naylon Give Kids a Chance Act
Expands FDA authority over rare pediatric disease research by strengthening pediatric study enforcement, extending pediatric incentives and funding, and clarifying orphan drug exclusivity
Plain-English overview
What this bill does
Expands FDA authority over rare pediatric disease research by strengthening pediatric study enforcement, extending pediatric incentives and funding, and clarifying orphan drug exclusivity
Key points
- Modify pediatric cancer investigations
- Allow FDA enforcement actions
- Extend rare disease vouchers
- Reauthorize pediatric research funding
Current status
Where it stands
Status
Introduced
Latest action
2025-12-02 — Received in the Senate.
Related context
Topics and policy areas
undefinedArab-Israeli relationsBahrainCancerChild healthComputers and information technologyCongressional oversightDrug safety, medical device, and laboratory regulation